Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly adds $375M to Zymeworks partnership
Yahoo/AP
Wednesday, October 22, 2014 - 7:00pm
tags:
Eli Lilly, Zymeworks, cancer immunotherapy
AbbVie finally admits it was trying to dodge U.S. taxes
Fortune
Wednesday, October 22, 2014 - 6:57pm
tags:
AbbVie, Shire, tax inversions, M&A
Roche blueprints a $1.8B R&D complex for pRED
Fierce Biotech
Wednesday, October 22, 2014 - 9:56am
tags:
Roche, R&D, pRED
Biogen drops after disclosure of Tecfidera patient death
Seeking Alpha
Wednesday, October 22, 2014 - 9:55am
tags:
Biogen Idec, Tecfidera
Intuitive Surgical Q3 Earnings Fall but Beat Estimates
Yahoo/Zacks.com
Wednesday, October 22, 2014 - 9:52am
tags:
Intuitive Surgical, earnings, devices
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Motley Fool
Wednesday, October 22, 2014 - 8:37am
tags:
Cubist Pharmaceuticals, Sivextro, Cubicin, anti-infectives, Zerbaxa
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Fierce Biotech
Wednesday, October 22, 2014 - 8:32am
tags:
GSK, ViiV Healthcare, IPOs, HIV, Pfizer
Mylan Faces Investor Pressure Over a Drug to be Used for Executions
WSJ Pharmalot
Wednesday, October 22, 2014 - 8:24am
tags:
Mylan Labs, execution drugs
Vertex Faces a Litmus Test for its Cystic Fibrosis Combo Treatment
WSJ Pharmalot
Wednesday, October 22, 2014 - 8:20am
tags:
Vertex Pharmaceuticals, cystic fibrosis, FDA, Kalydeco, advisory panels
Biogen posts 3Q profit, results top Street expectations
Yahoo/AP
Wednesday, October 22, 2014 - 8:06am
tags:
Biogen Idec, earnings
Boston Scientific matches 3Q earnings expectations, tops revenue forecasts
Yahoo/AP
Wednesday, October 22, 2014 - 8:05am
tags:
Boston Scientific, earnings, devices
Abbott Labs shares rise after profit tops forecasts
Marketwatch
Wednesday, October 22, 2014 - 8:04am
tags:
Abbott Labs, earnings
J&J, GSK ready to collaborate on Ebola vaccine work
Yahoo/Reuters
Wednesday, October 22, 2014 - 7:57am
tags:
JNJ, GSK, ebola virus, vaccines
J&J Says 250,000 Ebola Vaccine Doses to Be Ready by May
Bloomberg
Wednesday, October 22, 2014 - 7:56am
tags:
JNJ, vaccines, ebola virus, Janssen, Bavarian Nordic
GSK Q3 revenue disappoints with 3% fall to $8.9B
CNBC
Wednesday, October 22, 2014 - 7:54am
tags:
GSK, earnings
Biogen Leads 5 Top Biotech Stocks As Earnings Loom
Investors.com
Tuesday, October 21, 2014 - 9:55pm
tags:
Biogen Idec, earnings, Celgene, Alexion, Regeneron, Gilead Sciences
Tekmira begins limited manufacturing of drug targeting Ebola
Yahoo/Reuters
Tuesday, October 21, 2014 - 9:52pm
tags:
Tekmira Pharmaceuticals, ebola virus, TKM-EBOLA
Allergan keeps a few secrets, court filing shows
Marketwatch
Tuesday, October 21, 2014 - 4:46pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Will Quest Diagnostics (DGX) Surprise Earnings in Q3?
Yahoo/Zacks.com
Tuesday, October 21, 2014 - 4:44pm
tags:
Quest Diagnostics, earnings, diagnostics
Third Point wants Amgen to explore separation
Marketwatch
Tuesday, October 21, 2014 - 4:40pm
tags:
Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.